Safety and antitumor activity of a-PD-L1 antibody as monotherapy or in combination with a-TIM-3 antibody in patients with microsatellite instability-high/mismatch repair-deficient tumors
Nom du journal : Clin Cancer Res
Année : 2021
Volume : 27
Page de départ : 6393
Page de fin : 6404